Moran Elishmereni

980 total citations
20 papers, 753 citations indexed

About

Moran Elishmereni is a scholar working on Immunology, Modeling and Simulation and Oncology. According to data from OpenAlex, Moran Elishmereni has authored 20 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Modeling and Simulation and 7 papers in Oncology. Recurrent topics in Moran Elishmereni's work include Mathematical Biology Tumor Growth (9 papers), Immunotherapy and Immune Responses (6 papers) and Mast cells and histamine (5 papers). Moran Elishmereni is often cited by papers focused on Mathematical Biology Tumor Growth (9 papers), Immunotherapy and Immune Responses (6 papers) and Mast cells and histamine (5 papers). Moran Elishmereni collaborates with scholars based in Israel, United States and Italy. Moran Elishmereni's co-authors include Zvia Agur, Francesca Levi‐Schaffer, Yuri Kogan, Antonio Cappuccio, Stanimir Vuk‐Pavlović, David Mankuta, Natalie Kronik, Ido Bachelet, Yuri Kheifetz and Nicholas H. G. Holford and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Moran Elishmereni

20 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moran Elishmereni Israel 15 301 257 245 158 154 20 753
Anum Syed United States 13 65 0.2× 32 0.1× 111 0.5× 20 0.1× 198 1.3× 19 737
Amanda Tracz United States 10 61 0.2× 222 0.9× 227 0.9× 19 0.1× 283 1.8× 14 679
Antonella Ingrosso Italy 14 100 0.3× 24 0.1× 244 1.0× 12 0.1× 192 1.2× 25 635
Yuri Kogan Israel 14 162 0.5× 362 1.4× 317 1.3× 9 0.1× 248 1.6× 33 626
Eliezer Shochat Switzerland 12 73 0.2× 187 0.7× 234 1.0× 11 0.1× 302 2.0× 17 588
B Soehnlen United States 11 125 0.4× 19 0.1× 513 2.1× 41 0.3× 582 3.8× 15 1.2k
Matthew A. Smith United States 19 247 0.8× 15 0.1× 350 1.4× 15 0.1× 390 2.5× 38 1.1k
Carlos Fernández Moro Sweden 17 189 0.6× 11 0.0× 649 2.6× 24 0.2× 356 2.3× 43 1.2k
Irina Kareva United States 16 178 0.6× 171 0.7× 362 1.5× 18 0.1× 307 2.0× 44 836
Raheleh Salari United States 15 90 0.3× 15 0.1× 235 1.0× 18 0.1× 606 3.9× 29 1.0k

Countries citing papers authored by Moran Elishmereni

Since Specialization
Citations

This map shows the geographic impact of Moran Elishmereni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moran Elishmereni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moran Elishmereni more than expected).

Fields of papers citing papers by Moran Elishmereni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moran Elishmereni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moran Elishmereni. The network helps show where Moran Elishmereni may publish in the future.

Co-authorship network of co-authors of Moran Elishmereni

This figure shows the co-authorship network connecting the top 25 collaborators of Moran Elishmereni. A scholar is included among the top collaborators of Moran Elishmereni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moran Elishmereni. Moran Elishmereni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Foryś, Urszula, et al.. (2022). Mathematical model of hormone sensitive prostate cancer treatment using leuprolide: A small step towards personalization. PLoS ONE. 17(2). e0263648–e0263648. 4 indexed citations
2.
Agur, Zvia, Moran Elishmereni, Urszula Foryś, & Yuri Kogan. (2020). Accelerating the Development of Personalized Cancer Immunotherapy by Integrating Molecular Patients’ Profiles with Dynamic Mathematical Models. Clinical Pharmacology & Therapeutics. 108(3). 515–527. 11 indexed citations
3.
Kogan, Yuri, Moran Elishmereni, Ronen Brenner, et al.. (2018). A new algorithm predicting imminent disease progression in advanced NSCLC patients by machine-learning integration of five serum biomarkers.. Journal of Clinical Oncology. 36(15_suppl). e21190–e21190. 1 indexed citations
4.
Elishmereni, Moran, Yuri Kheifetz, Graham H. Bevan, et al.. (2015). Predicting time to castration resistance in hormone sensitive prostate cancer by a personalization algorithm based on a mechanistic model integrating patient data. The Prostate. 76(1). 48–57. 19 indexed citations
5.
Agur, Zvia, Moran Elishmereni, & Yuri Kheifetz. (2014). Personalizing oncology treatments by predicting drug efficacy, side‐effects, and improved therapy: mathematics, statistics, and their integration. WIREs Systems Biology and Medicine. 6(3). 239–253. 29 indexed citations
6.
Elishmereni, Moran, Nanna Fyhrquist, Roopesh Singh Gangwar, et al.. (2014). Complex 2B4 Regulation of Mast Cells and Eosinophils in Murine Allergic Inflammation. Journal of Investigative Dermatology. 134(12). 2928–2937. 23 indexed citations
7.
Ribba, Benjamin, Nicholas H. G. Holford, Paolo Magni, et al.. (2014). A Review of Mixed‐Effects Models of Tumor Growth and Effects of Anticancer Drug Treatment Used in Population Analysis. CPT Pharmacometrics & Systems Pharmacology. 3(5). 1–10. 134 indexed citations
8.
Kogan, Yuri, Zvia Agur, & Moran Elishmereni. (2013). A mathematical model for the immunotherapeutic control of the Th1/Th2 imbalance in melanoma. Discrete and Continuous Dynamical Systems - B. 18(4). 1017–1030. 20 indexed citations
9.
Kogan, Yuri, et al.. (2012). Reconsidering the Paradigm of Cancer Immunotherapy by Computationally Aided Real-time Personalization. Cancer Research. 72(9). 2218–2227. 44 indexed citations
10.
Elishmereni, Moran, et al.. (2012). Interacting mast cells and eosinophils acquire an enhanced activation state in vitro. Allergy. 68(2). 171–179. 54 indexed citations
11.
Elishmereni, Moran, Yuri Kheifetz, Henrik Søndergaard, Rune Viig Overgaard, & Zvia Agur. (2011). An Integrated Disease/Pharmacokinetic/Pharmacodynamic Model Suggests Improved Interleukin-21 Regimens Validated Prospectively for Mouse Solid Cancers. PLoS Computational Biology. 7(9). e1002206–e1002206. 21 indexed citations
12.
Kronik, Natalie, et al.. (2010). Predicting Outcomes of Prostate Cancer Immunotherapy by Personalized Mathematical Models. PLoS ONE. 5(12). e15482–e15482. 99 indexed citations
13.
Elishmereni, Moran & Francesca Levi‐Schaffer. (2010). CD48: A co-stimulatory receptor of immunity. The International Journal of Biochemistry & Cell Biology. 43(1). 25–28. 57 indexed citations
14.
Elishmereni, Moran, Harri Alenius, Peter Bradding, et al.. (2010). Physical interactions between mast cells and eosinophils: a novel mechanism enhancing eosinophil survival in vitro. Allergy. 66(3). 376–385. 76 indexed citations
15.
Elishmereni, Moran, et al.. (2010). Ultrastructural evidence for human mast cell-eosinophil interactions in vitro. Cell and Tissue Research. 341(3). 405–415. 45 indexed citations
16.
Elishmereni, Moran, et al.. (2008). Mast Cell-Eosinophil Cross-Talk Regulates Function and Viability of Both Cells in Vitro. Journal of Allergy and Clinical Immunology. 121(2). S110–S110. 1 indexed citations
17.
Elishmereni, Moran, Ido Bachelet, & Francesca Levi‐Schaffer. (2008). DNAM-1: an amplifier of immune responses as a therapeutic target in various disorders.. PubMed. 9(5). 491–6. 14 indexed citations
18.
Cappuccio, Antonio, Moran Elishmereni, & Zvia Agur. (2007). Optimization of interleukin-21 immunotherapeutic strategies. Journal of Theoretical Biology. 248(2). 259–266. 17 indexed citations
19.
Cappuccio, Antonio, Moran Elishmereni, & Zvia Agur. (2006). Cancer Immunotherapy by Interleukin-21: Potential Treatment Strategies Evaluated in a Mathematical Model. Cancer Research. 66(14). 7293–7300. 83 indexed citations
20.
Kheifetz, Yuri, et al.. (2006). Fluid‐Retention Side‐Effects of the Chemotherapy‐Supportive Treatment Interleukin‐11: Mathematical Modelling of Putative Underlying Mechanisms. Computational and Mathematical Methods in Medicine. 7(2-3). 71–84. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anum Syed Breakdown of academic impact, for papers by Amanda Tracz Breakdown of academic impact, for papers by Antonella Ingrosso Breakdown of academic impact, for papers by Yuri Kogan Breakdown of academic impact, for papers by Eliezer Shochat Breakdown of academic impact, for papers by B Soehnlen Breakdown of academic impact, for papers by Matthew A. Smith Breakdown of academic impact, for papers by Carlos Fernández Moro Breakdown of academic impact, for papers by Irina Kareva Breakdown of academic impact, for papers by Raheleh Salari
Rankless by CCL
2026